|
Originally published In Press as doi:10.1074/jbc.M102668200 on July 19, 2001
J. Biol. Chem., Vol. 276, Issue 40, 36902-36908, October 5, 2001
Herpesvirus saimiri Replaces ZAP-70 for CD3- and
CD2-mediated T Cell Activation*
Edgar
Meinl §¶,
Tobias
Derfuss ,
Rainer
Pirzer ,
Norbert
Blank**,
Doris
Lengenfelder ,
Antoine
Blancher ,
Françoise
Le Deist§§,
Bernhard
Fleckenstein , and
Claire
Hivroz¶¶
From the Department of Neuroimmunology,
Max-Planck-Institute of Neurobiology, D-82152 Martinsried,
Germany, § Institute for Clinical Neuroimmunology,
Ludwig-Maximilians-University, 81377 Munich, Germany, Institute
for Clinical and Molecular Virology, University
Erlangen-Nürnberg, 91054 Erlangen, Germany,
** Department of Internal Medicine III and Institute for
Clinical Immunology, University of Erlangen-Nürnberg, 91054 Erlangen, Germany,  Hôpital Purpan,
31059 Toulouse, France, §§ INSERM U429,
Hôpital Necker, 75015 Paris, France and ¶¶ INSERM
U520, Institut Curie, 75248 Paris, France
The protein tyrosine kinase ZAP-70 plays a
pivotal role involved in signal transduction through the T cell
receptor and CD2. Defects in ZAP-70 result in severe combined
immunodeficiency. We report that Herpesvirus saimiri, which
does not code for a ZAP-70 homologue, can replace this tyrosine kinase.
H. saimiri is an oncogenic virus that transforms human T
cells to stable growth based on mutual CD2-mediated activation.
Although CD2-mediated proliferation of ZAP-70-deficient uninfected T
cells was absent, we could establish H. saimiri-transformed
T cell lines from two unrelated patients presenting with ZAP-70
deficiencies. In these cell lines, CD2 and CD3 activation were restored
in terms of [Ca2+]i, MAPK activation, cytokine
production, and proliferation. Activation-induced tyrosine
phosphorylation of remained defective. The transformed cells
expressed very high levels of the ZAP-70-related kinase Syk. This
increased expression was not observed in the primary T cells from the
patients and was not due to the transformation by the virus because
transformed cell lines established from control T cells did not present
this particularity. In conclusion, wild type H. saimiri can
restore CD2- and CD3-mediated activation in signaling-deficient human T
cells. It extends our understanding of interactions between the
oncogenic H. saimiri and the infected host cells.
*
This work was supported by the Deutsche
Forschungsgemeinschaft (SFB 466 and SFB 571) and the Wilhelm
Sander-Stiftung (97.081.1). The Institute of Clinical Neuroimmunology
is supported by the Hermann and Lilly Schilling Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of
Neuroimmunology, Max-Planck-Institute of Neurobiology, D-82152
Martinsried, Germany. Tel.: 49-89-8578-3519; Fax: 49-89-8995-0163;
E-mail: meinl@neuro.mpg.de.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. Heck, U. Friedrich, M. U. Gack, D. Lengenfelder, M. Schmidt, I. Muller-Fleckenstein, B. Fleckenstein, A. Ensser, and B. Biesinger
Growth transformation of human T cells by herpesvirus saimiri requires multiple tip-lck interaction motifs.
J. Virol.,
October 1, 2006;
80(20):
9934 - 9942.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Sorokina, J. J. Merlo Jr., and A. Y. Tsygankov
Molecular Mechanisms of the Effect of Herpesvirus saimiri Protein StpC on the Signaling Pathway Leading to NF-{kappa}B Activation
J. Biol. Chem.,
April 2, 2004;
279(14):
13469 - 13477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. S. Torres, D. A. Zapata, A. Pacheco-Castro, J. L. Rodriguez-Fernandez, C. Cabanas, and J. R. Regueiro
Contribution of CD3{gamma} to TCR regulation and signaling in human mature T lymphocytes
Int. Immunol.,
November 1, 2002;
14(11):
1357 - 1367.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|